[go: up one dir, main page]

WO2001050128A3 - Use of non-specific igg in calibrating immunoassays for autoantibodies - Google Patents

Use of non-specific igg in calibrating immunoassays for autoantibodies Download PDF

Info

Publication number
WO2001050128A3
WO2001050128A3 PCT/BE2000/000157 BE0000157W WO0150128A3 WO 2001050128 A3 WO2001050128 A3 WO 2001050128A3 BE 0000157 W BE0000157 W BE 0000157W WO 0150128 A3 WO0150128 A3 WO 0150128A3
Authority
WO
WIPO (PCT)
Prior art keywords
specific igg
autoantibodies
immunoassays
calibrating
auto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BE2000/000157
Other languages
French (fr)
Other versions
WO2001050128A2 (en
Inventor
Alain Bosseloir
Jean-Claude Havaux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZEN TECH SA
HAVAUX JEAN CLAUDE
Zen Tech S A
Original Assignee
ZEN TECH SA
HAVAUX JEAN CLAUDE
Zen Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZEN TECH SA, HAVAUX JEAN CLAUDE, Zen Tech S A filed Critical ZEN TECH SA
Priority to AU23334/01A priority Critical patent/AU2333401A/en
Publication of WO2001050128A2 publication Critical patent/WO2001050128A2/en
Publication of WO2001050128A3 publication Critical patent/WO2001050128A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention is related to a method for determining the concentration of auto-antibodies in a biological sample, obtained from a mammal suffering from an auto-immune disease. The invention is characterized by the use of a calibration curve derived from solutions of non-specific IgG obtained from healthy patients.
PCT/BE2000/000157 1999-12-30 2000-12-22 Use of non-specific igg in calibrating immunoassays for autoantibodies Ceased WO2001050128A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23334/01A AU2333401A (en) 1999-12-30 2000-12-22 Method for determining a concentration of auto-antibodies in a biological sampleby using a common standard curve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17393599P 1999-12-30 1999-12-30
US60/173,935 1999-12-30

Publications (2)

Publication Number Publication Date
WO2001050128A2 WO2001050128A2 (en) 2001-07-12
WO2001050128A3 true WO2001050128A3 (en) 2002-02-07

Family

ID=22634124

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE2000/000157 Ceased WO2001050128A2 (en) 1999-12-30 2000-12-22 Use of non-specific igg in calibrating immunoassays for autoantibodies

Country Status (2)

Country Link
AU (1) AU2333401A (en)
WO (1) WO2001050128A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210364531A1 (en) * 2020-05-19 2021-11-25 Laboratory Corporation Of America Holdings Methods and Systems for Quantitative Detection of Antibodies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041389A (en) * 1986-01-06 1991-08-20 The Salk Institute For Biological Studies Assays for myasthenia gravis
EP0651253A1 (en) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay for the detection of human autoantibodies
US5639625A (en) * 1994-09-26 1997-06-17 Oklahoma Medical Research Foundation Method for detecting antibodies to thrombomodulin in patients

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041389A (en) * 1986-01-06 1991-08-20 The Salk Institute For Biological Studies Assays for myasthenia gravis
EP0651253A1 (en) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay for the detection of human autoantibodies
US5639625A (en) * 1994-09-26 1997-06-17 Oklahoma Medical Research Foundation Method for detecting antibodies to thrombomodulin in patients

Also Published As

Publication number Publication date
AU2333401A (en) 2001-07-16
WO2001050128A2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
AU2002327037A1 (en) Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
NO20006681D0 (en) Procedure for early diagnosis of carcinomas
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
ATE348843T1 (en) DETECTION OF TSH RECEPTOR AUTOANTIBODIES USING AFFINITY PURIFIED ANTIBODIES
DE60228557D1 (en) CANDIDA-PROOF
IL205206A (en) Method for distinguishing in a sample an anti-drug antibody to humanized anti inflammatory drug antibody from an anti-human igg antibody with an immunoassay
WO2005054853A3 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
JP6226976B2 (en) Method for detecting multispecific binders
WO2002014870A3 (en) Use of antibodies against specific mhc-peptide complexes
RU2017114626A (en) ANTI-BODY BINDING LINEAR EPITHOPE OF HUMAN P53, AND ITS APPLICATION IN DIAGNOSTICS
AU2002343076A1 (en) Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
AU2002233800A1 (en) Method and kit for predicting cancer
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease
EP1245957A3 (en) Method of measuring ceruloplasmin concentration with enzyme-linked immunosorbent assay or dissociation-enhanced time-resolved fluoroimmunoassay in a blood spot, and Wilson's disease screening kit and method of diagnosing Wilson's disease
WO2001050128A3 (en) Use of non-specific igg in calibrating immunoassays for autoantibodies
AU5352901A (en) Method for quantification of akt protein expression
WO2001055346A3 (en) System for the internal qualitative and quantitative validation of marker indices
CA2346406A1 (en) Detection of pleiotrophin
WO2004033628A3 (en) Use of monoclonal antibodies to distinguish protein conformational isoforms
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
ATE237640T1 (en) MONOCLONAL ANTIBODY AGAINST THROMBIN-ANTITHROMBIN COMPLEX-III AND ITS USE IN IMMUNOASSAYS
DE602005025559D1 (en) Diagnostic test for human matrix Gla protein and its use as a biomarker
AU2001274239A1 (en) Neurotransmission disorders
SE9602234D0 (en) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
Koivisto et al. Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP